The effect of a combination of plant sterol-enriched foods in mildly hypercholesterolemic subjects.

Clin Nutr

Department of Cardiology, Center for Cardiovascular Research, Arhus University Hospitals, Aalborg Hospital, Sdr. Skovvej 15, 9000 Aalborg, Denmark.

Published: December 2007

AI Article Synopsis

  • The study assessed how low-fat products with added plant sterols impact cholesterol levels in people with slightly high cholesterol.
  • The research involved 46 participants who followed a specific diet and consumed either plant sterol products or a placebo over two 4-week periods.
  • Results showed significant reductions in total cholesterol, low-density lipoprotein (LDL) cholesterol, and apolipoprotein B levels with plant sterol-enriched products, but no changes in certain inflammation markers.

Article Abstract

Background & Aims: The purpose of this study was to evaluate the effect of low-fat products enriched with plant sterols in addition to a National Cholesterol Education Program step 1 diet on serum lipids and lipoproteins.

Methods: This study was a double-blind, randomised, placebo-controlled cross-over design with a run-in period and 2 intervention periods, each lasting 4 weeks. A total of 46 mildly hypercholesterolemic subjects (age 50.6+/-9.8) completed the trial. The study products consisted of 20 g low-fat margarine (35% fat) and 250 ml low-fat milk (0.7% fat), in total delivering 2.3g plant sterols/d.

Results: Serum total and low-density lipoprotein cholesterol were significantly reduced by 5.5% (p<0.001, 95% CI: 2.5; 8.3) and 7.7% (p=0.001, 95% CI: 3.4; 11.9), respectively, by plant sterol-enriched products compared to placebo. Serum apolipoprotein B was significantly reduced by 4.6% (p<0.05, 95% CI: 1.7; 7.5), and apolipoprotein B/apolipoprotein A-I by 3.4% (p<0.05, 95% CI: 0.1; 6.6) after plant sterol intake compared to the placebo supplement.

Conclusions: A combination of low-fat margarine and milk enriched with plant sterols significantly reduced low-density lipoprotein cholesterol, apolipoprotein B and the ratio of apolipoprotein B to apolipoprotein A-I in mildly hypercholesterolemic subjects, but had no effect on C-reactive protein and lipoprotein (a) concentrations.

Sponsorship: Unilever Denmark A/S.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clnu.2007.05.008DOI Listing

Publication Analysis

Top Keywords

mildly hypercholesterolemic
8
hypercholesterolemic subjects
8
combination plant
4
plant sterol-enriched
4
sterol-enriched foods
4
foods mildly
4
subjects background
4
background aims
4
aims purpose
4
purpose study
4

Similar Publications

Objective: We questioned whether the baseline status of low-density lipoprotein cholesterol (LDL-C), cholesterol synthesis and absorption, and the changes in these parameters determine the change in serum LDL-C under statin or ezetimibe treatment or under combination treatment.

Materials And Methods: 37 mildly hypercholesterolemic healthy male subjects were studied under placebo, simvastatin (20 mg/d), ezetimibe (10 mg/d), and combination treatment. We correlated the change of LDL-C (ΔLDL-C) under treatment with the placebo end values of LDL-C (baseline), whole-body cholesterol synthesis, and hepatic cholesterol synthesis (serum lathosterol to cholesterol ratio) as well as fractional absorption rate (FAR) of cholesterol and serum campesterol to cholesterol ratio.

View Article and Find Full Text PDF

Introduction: The scientific community and consumers are increasingly interested in the potential cholesterol-lowering effect of various nutraceuticals and their combinations. The aim of our study was to test the short-term effect of a new lipid-lowering nutraceutical formulation in mildly hypercholesterolemic patients.

Material And Methods: We consecutively enrolled 80 mildly hypercholesterolemic patients with low-density lipoprotein-cholesterol (LDL-C) between 130 and 190 mg/dl with a low-estimated cardiovascular disease risk.

View Article and Find Full Text PDF

Aims: Specific fibroblast markers and in-depth heterogeneity analysis are currently lacking, hindering functional studies in cardiovascular diseases (CVDs). Here, we established cell-type markers and heterogeneity in murine and human arteries and studied the adventitial fibroblast response to CVD and its risk factors hypercholesterolaemia and ageing.

Methods And Results: Murine aorta single-cell RNA-sequencing analysis of adventitial mesenchymal cells identified fibroblast-specific markers.

View Article and Find Full Text PDF
Article Synopsis
  • Participants (109 healthy men) received either Aronia or a placebo for 90 days, focusing on health outcomes like cholesterol levels, sperm quality, and antioxidant glutathione levels, with variations based on age, lifestyle, and dietary habits.
  • Results showed that Aronia supplementation improved glutathione in men with low baseline levels and high coffee intake, reduced sperm DNA fragmentation and increased motile sperm in older and overweight men, and lowered cholesterol in younger men, but other health parameters showed no significant changes.
View Article and Find Full Text PDF

Introduction. Pharmacological reduction of cholesterol (C) synthesis and C absorption lowers serum low-density lipoprotein C (LDL-C) concentrations. We questioned whether high baseline C synthesis or C absorption translates into high serum LDL-C concentrations or if there was no connection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!